🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05270616
Recruiting Not applicable

Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery

NCT05270616 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Shandong University
Phase
Not applicable
Started
2020-06-01
Last updated
2022-03-08

Condition(s) studied

Lung DiseasesSurgery

Investigational drug(s) / intervention(s)

robotic surgeryuniport surgerymultiple- port surgery

robotic surgery: minimally invasive surgery using the Davinci robotic system

uniport surgery: VATS minimally invasive surgery under the uniportal status

multiple- port surgery: VATS minimally invasive surgery under the multiple- port status

Study summary

To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection.

Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy; Exclusion Criteria: 1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Hospital of Shandong University Jinan Shandong Recruiting

More The Second Hospital of Shandong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05270616 on ClinicalTrials.gov ↗ ← All trials in China